SBTX NASDAQ
Silverback Therapeutics, Inc.
1W: -4.5%
1M: +16.5%
3M: +16.7%
1Y: -33.3%
$5.87
Last traded 2022-11-08 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$117M
Revenue
+4.1% YoY
$-215M
Net Income
-348.7% YoY
$-197M
Free Cash Flow
-268.3% YoY
0.0%
Gross Margin
-182.6%
Op. Margin
-185.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-210.3%
ROA-76.5%
ROIC130.1%
Valuation
P/E-2.7
P/B46.6
EV/EBITDA-2.8
Leverage
Debt/Equity0.00
Current Ratio3.48
Interest Cov.-6.8x
Quality Scores
Piotroski F3/9
Altman Z-0.35
Beneish M-1.75